Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove. (2023)
Attributed to:
MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.156643
PubMed Identifier: 36810251
Publication URI: http://europepmc.org/abstract/MED/36810251
Type: Journal Article/Review
Volume: 8
Parent Publication: JCI insight
Issue: 4
ISSN: 2379-3708